Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesGenomic Sequencing Procedures and Other Molecular Multianalyte AssaysCPT cpt-81425-whole-genome-sequence-analysis-unexplained-disorder
    Ask Trek AI about this page

    CPT 81425: Whole Genome Sequencing for Diagnostic Evaluation

    Commercial payers pay $4542 on average nationally for this procedure.

    CPT code 81425 describes a clinical laboratory service performing comprehensive whole genome sequencing to analyze the patient's entire genomic sequence for genetic variants that may explain an unexplained disorder or syndrome; this is a genomic sequencing diagnostic test typically performed as a clinical diagnostic laboratory service with the typical site of service being an outpatient or inpatient clinical laboratory affiliated with a hospital or specialized genetics testing center.

    For related coverage guidance, see recent payer policy updates: Minimal Residual Disease (MRD) Testing for Cancer, Biomarker Testing Mandate, Prenatal (Fetal) Diagnostic Testing.

    Customize your policy alerts

    Sign up for cpt 81425 policy alerts

    Get alerted when payer policies referencing 81425 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    National Reimbursement Benchmarks

    National commercial reimbursement for CPT 81425 centers around the BUCA average commercial benchmark of $4,542.30, with payers showing meaningful variation around that midpoint. Blue Cross Blue Shield has one of the widest dispersions between the 25th and 75th percentiles (P75 $6,006.40 minus P25 $3,217.00 = $2,789.40), closely followed by Cigna (P75 $6,643.00 minus P25 $2,581.40 = $4,061.60) and UnitedHealth Group (P75 $5,031.20 minus P25 $2,113.10 = $2,918.10). Aetna displays a narrower interquartile spread (P75 $5,031.20 minus P25 $1,720.70 = $3,310.50) relative to Cigna and UnitedHealth Group but wider than some peers.

    Dispersion highlights that Cigna exhibits the widest IQR at $4,061.60, signaling greater variability in mid‑range commercial payments, while Blue Cross Blue Shield and UnitedHealth Group also show substantial spreads of $2,789.40 and $2,918.10 respectively. BUCA’s average of $4,542.30 sits near payer medians overall, underscoring that commercial pricing for this code clusters around the mid single‑ to low five‑thousand dollar range despite notable inter‑payer variability.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    National Payer Mean Reimbursement Rates

    State Reimbursement Rates

    State: Alaska1 / 51

    Rate by payer

    Clinical & Coding Specifications

    Clinical Context

    A pediatric patient is referred to a clinical genetics laboratory after presenting with multiple congenital anomalies, global developmental delay, and failure to thrive. Prior targeted genetic tests (chromosomal microarray and single-gene sequencing panels) were nondiagnostic. The clinician orders a comprehensive genome sequencing analysis to identify single nucleotide variants, small insertions/deletions, and structural variants across the entire genome. The typical workflow includes: sample collection (peripheral blood), accessioning, DNA extraction, library preparation, high-throughput sequencing, bioinformatic alignment and variant calling, multidisciplinary variant interpretation by a board-certified clinical molecular geneticist and laboratory director, and generation of a diagnostic report. Results may identify pathogenic or likely pathogenic variants explaining diagnoses such as Q90.9 (Down syndrome, if mosaic or atypical presentation), Q99.9 (chromosomal abnormality, unspecified), Q87.1 (congenital malformation syndromes), Q89.9 (congenital malformation, unspecified), or metabolic disorders like E88.9. Typical site of service is an outpatient clinical genetics or molecular diagnostics laboratory; sequencing may be ordered by specialists in genetics, pediatrics, neurology, or metabolic disease. The service type is comprehensive genome sequencing (diagnostic whole genome sequencing) performed for evaluation of unexplained genetic disorders.

    Related CPT Codes

    CPT CodeDescription

    Related Modifiers

    8 rows

    ModifierDescriptionWhen to Use
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    90Modifier ‑90 (Reference/Outside Laboratory) indicates that a laboratory test was performed by an entity other than the treating or reporting provider. The American Medical Association defines…- Use CPT modifier -90 when a laboratory test is performed by an outside/reference laboratory (an entity other than the treating or reporting physician or qualified professional) and the claim needs…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    62Modifier 62 indicates that two surgeons function as co‑surgeons, each performing distinct parts of the same primary surgical procedure. It is appended to the primary procedure code (and any…- Use modifier -62 when two surgeons act as co‑surgeons (both primary surgeons) on a single definitive primary procedure, each performing distinct parts of the same surgical procedure (append -62 to…
    80CPT® Modifier 80 (Assistant Surgeon) is appended to a surgical CPT code when a physician (MD or DO) provides full, continuous assistance throughout the operative procedure. It is intended only for…- Use CPT Modifier -80 when a physician (MD or DO) serves as an assistant surgeon and provides full, continuous assistance throughout the entire operative procedure; append -80 to the surgical CPT…
    22Modifier –22 (Increased Procedural Services) is used when a reported procedure is substantially more extensive than normally required. The CPT Manual and CMS state it may be appended only when the…- When to use: Append modifier -22 to a procedural CPT code when the service performed is substantially more extensive than the usual service described by that code — i.e., the procedure required…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207SG0201X
    207SG0202X
    207SG0205X
    207SG0203X
    313M00000X
    323P00000X
    246QH0000X
    2279G1100X

    Related ICD-10-CM Codes

    28 rows

    ICD-10-CM CodeDescription
    D82.9Immunodeficiency associated with major defect, unspecified
    D84.9Immunodeficiency, unspecified
    E70.9Disorder of aromatic amino-acid metabolism, unspecified
    E88.9Metabolic disorder, unspecified
    F80.9Developmental disorder of speech and language, unspecified
    F82Specific developmental disorder of motor function
    G31.84Mild cognitive impairment of uncertain or unknown etiology
    G40.909Epilepsy, unspecified, not intractable, without status epilepticus
    H53.8Other visual disturbances
    H90.3Sensorineural hearing loss, bilateral

    Showing 1–10 of 28

    Related Payer Policy Updates

    Specialty: Genetic & Molecular Testing1 / 3

    10 rows

    PolicyPayerEffective Date
    Minimal Residual Disease (MRD) Testing for Cancerregence2027-01-01
    Biomarker Testing MandateBlue Cross Blue Shield - Rhode Island2027-01-01
    Prenatal (Fetal) Diagnostic TestingBlue Cross Blue Shield - Rhode Island2027-01-01
    Oral Cancer Screening and TestingOscar Health2027-01-01
    RTM Testing for Alpha-1 Antitrypsin DeficiencyOscar Health2027-01-01
    Cytochrome P450 Genotype-Guided Treatment Strategy Corporate Medical Policybcbsvermont2027-01-01
    Cytochrome P450 Genotypingblue cross blue shield - tennessee2026-12-31
    Polygenic Risk ScoreBlue Cross Blue Shield - Rhode Island2026-12-01
    Gene Expression Profiling for Cutaneous MelanomaBlue Cross Blue Shield - Rhode Island2026-12-01
    Chromosomal Microarray Testing for the Evaluation of Pregnancy Lossblue_shield_of_california2026-11-01

    Related Codes

    CPT-81410-GENOMIC-PANEL-AORTIC-DISEASE

    CPT 81410: Heritable Thoracic Aortic Disease Targeted Gene Panel

    CPT-81411-GENETIC-DUPLICATION-DELETION-PANEL-AORTIC-DISEASE

    CPT 81411: Genetic Panel for Aortic Dysfunction Copy Number Analysis

    CPT-81412-ASHKENAZI-JEWISH-GENOMIC-SEQUENCE-PANEL

    CPT 81412: Ashkenazi Jewish–Associated Genetic Sequence Panel

    CPT-81413-GENOMIC-PANEL-CARDIAC-ION-CHANNELOPATHIES

    CPT 81413: Cardiac Ion Channelopathy Targeted Gene Panel

    CPT-81414-CARDIAC-ION-CHANNELOPATHY-CNV-PANEL

    CPT 81414: Cardiac Ion Channelopathy Copy Number Variant Panel

    CPT-81415-EXOME-SEQUENCE-ANALYSIS-UNEXPLAINED-DISORDER

    CPT 81415: Exome Sequence Analysis for Unexplained Disorder

    CPT-81416-FAMILIAL-EXOME-SEQUENCE-ANALYSIS

    CPT 81416: Relative Exome Sequence Analysis for Reference Exome

    CPT-81417-EXOME-SEQUENCE-REEVALUATION

    CPT 81417: Exome Reanalysis for New Clinical Information

    CPT-81418-PHARMACOGENOMIC-MULTIGENE-DRUG-METABOLISM-PANEL

    CPT 81418: Pharmacogenetic Multigene Panel Including CYP2C19 and CYP2D6

    CPT-81419-GENOMIC-SEQUENCE-PANEL-EPILEPSY

    CPT 81419: Genomic Sequence Analysis Panel for Epilepsy

    Showing 1–10 of 43

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Relationship to This Procedure
    81422Genomic sequencing procedure, advanced molecular analytics (subset)May be used for targeted or smaller genomic panels when whole genome sequencing is not indicated; often performed before or instead of 81425.
    81443Genomic sequencing procedure, interpretation and reporting of tumor or constitutional sequencing (larger panels)Used for larger panel or exome-level analyses; may complement or be an alternative to whole genome sequencing.
    81426Genomic sequencing procedure, additional interpretation or specialized analysisBilled for add-on or supplemental genomic analyses or expanded interpretation services that accompany primary genome sequencing.